Biotest Aktiengesellschaft (BIO) — Cash Flow Quality Index
Biotest Aktiengesellschaft (BIO) has a Cash Flow Quality Index of 6.02x as of June 2024. Operating cash flow of €58.40 Million exceeds net income of €9.70 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of Biotest Aktiengesellschaft to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Biotest Aktiengesellschaft Cash Flow Quality Index (2002–2024)
Historical Cash Flow Quality Index for Biotest Aktiengesellschaft across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Biotest Aktiengesellschaft cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Biotest Aktiengesellschaft (2002–2024)
Year-by-year earnings quality comparison for Biotest Aktiengesellschaft. For live market cap and the full company financial profile, see BIO market cap overview.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.31x | €60.90 Million | €26.40 Million | ▲ +10950.6% |
| 2023 | -0.02x | €-2.70 Million | €127.00 Million | ▲ +98.3% |
| 2022 | -1.28x | €-40.50 Million | €31.70 Million | ▼ -202.2% |
| 2016 | 1.25x | €65.90 Million | €52.70 Million | ▲ +614.4% |
| 2014 | -0.24x | €-11.40 Million | €46.90 Million | ▼ -61.4% |
| 2013 | -0.15x | €-7.20 Million | €47.80 Million | ▼ -115.8% |
| 2012 | 0.95x | €34.73 Million | €36.48 Million | ▼ -62.4% |
| 2011 | 2.53x | €72.28 Million | €28.58 Million | ▼ -7.5% |
| 2010 | 2.74x | €77.83 Million | €28.45 Million | ▲ +322.8% |
| 2009 | 0.65x | €31.68 Million | €48.97 Million | ▼ -24.0% |
| 2008 | 0.85x | €34.49 Million | €40.53 Million | ▼ -80.3% |
| 2004 | 4.32x | €25.29 Million | €5.85 Million | ▲ +37.2% |
| 2003 | 3.15x | €16.52 Million | €5.24 Million | ▲ +2433.7% |
| 2002 | 0.12x | €2.46 Million | €19.80 Million | — |